Antimicrobial Peptides
Multidomain recombinant proteins that combine host defense peptides to overcome antibiotic resistance.
Combating antimicrobial resistance and advancing gene therapy through computational design and experimental validation.
Multidomain recombinant proteins that combine host defense peptides to overcome antibiotic resistance.
Functional inclusion bodies and leucine-zipper scaffolds as bioactive nanomaterials.
Applying deep learning to antimicrobial peptide discovery and capsid optimization.
Directed evolution of AAV capsids for improved tissue targeting and CAR-T cell transduction.
Engineering protein aggregates as bioactive nanoparticles for pharmaceutical applications.
Preclinical AAV vector evaluation using ex situ liver perfusion and humanized mouse models.
My background spans from a Biotechnology degree in Barcelona to a Masters in Biomedical Engineering at UC Irvine. During my PhD, I spent four years on multidomain antimicrobial protein design, leading to two patents.
At the Children's Medical Research Institute (CMRI) in Sydney, I built and led a computational peptide discovery platform. I combined large-scale sequence analysis, protein language models, and GPU-accelerated pipelines to design and experimentally validate over 100 antimicrobial peptide candidates.
I also contributed heavily to AAV capsid engineering and directed evolution for gene therapies. I don't use computation as a replacement for the bench, but to explore spaces and sequences that no bench can cover alone.
Built and led a computational peptide discovery platform combining large-scale sequence analysis, protein language models, and GPU pipelines. Designed and experimentally validated over 100 antimicrobial peptide candidates.
Started a new antimicrobial peptide research line from scratch; designed broad-spectrum recombinant proteins, filed 2 patents and published 8 papers.
Tracked estrogen receptor dynamics in living cells using single-molecule fluorescence microscopy and quantitative image analysis.
Microbial Cell Factories
We fused multiple antimicrobial domains into single recombinant polypeptides that outperform their individual parts against resistant bacteria.
Microbial Cell Factories
Leucine zippers drive controlled protein aggregation into bioactive nanoparticles — opening a new class of biomaterials for drug delivery.
Bridging computation and biology. 20+ publications, 300+ citations, and 2 patents in antimicrobial drug discovery and protein engineering.
ramon.rocap@gmail.com